Aurora & MedReleaf

Seizing an unprecedented opportunity to satisfy massive global demand for high quality legal, regulated cannabis product

  • Aurora Cannabis Inc.
1

Strategic Rationale

The Aurora Cannabis-MedReleaf transaction is a compelling combination bringing together the best of the cannabis industry and creating a powerful platform for global expansion. Through enhanced scale, liquidity, and a stable of complementary assets in Canada and internationally, the combined company is primed to accelerate growth ahead of domestic consumer legalization, and to seize an unprecedented opportunity to satisfy massive global demand for high quality legal, regulated medical cannabis products.

  • 11

    State-of-the-art Facilities

  • >570,000 kg

    Funded Capacity

Key Benefits

3

Joint Tax Election

Procedures for Making the Joint Tax Election

Pursuant to the terms of the Aurora Notice of Special Meeting of Shareholders dated July 18, 2018, Eligible Holders who receives Aurora Shares under the Plan of Arrangement are entitled to make an income tax election pursuant to subsection 85(1) of the Tax Act, or subsection 85(2) of the Tax Act if such beneficial owner is a partnership, with respect to the transfer of its MedReleaf Common Shares for Aurora Shares.

An Eligible Holder who desires to realize a portion only of the gain or loss is urged to consult their own tax advisors in this regard, including with respect to the possibility of making this joint tax election. 

A Tax Instruction Letter providing certain information and instruction on how to complete the Tax Election forms can be on https://www.taxelection.ca/medreleaf/.

5

Frequently Asked Questions

FAQs relating to the:

6

Contact Information

Shareholders Questions

Laurel Hill Advisory Group

Questions may be directed to Aurora's Information Agent at:

North America Toll Free: 1-877-452-7184

Collect Calls Outside North America: 1-416-304-0211

Email: assistance@laurelhill.com

Further Information